Home | Cancers | Prostate Cancer

Prostate Cancer

Men who are uneducated about their prostate cancer have difficulty making treatment choices

UCLA study finds that ‘decisional conflict’ could negatively impact quality of care and long-term outcomes ...

Large Study Reveals New Genetic Variants that Raise Risk for Prostate Cancer

In an analysis of genetic information among more than 87,000 men, a global team of scientists says it has found 23 new ...

Prostate cancer patients who receive hypofractionated radiation therapy report consistent quality of life before and after treatment

Prostate cancer patients who received hypofractionated (HPFX) radiation therapy (RT) reported that their quality of life, as well as bladder and bowel function were at similar levels before and after RT, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting. Additionally, results indicate that parallel quality of life outcomes occurred between groups of patients who receive different regimens of HPFX RT. ... Full story

Majority of prostate cancer patients surveyed five years after treatment with vessel-sparing radiation therapy report preserved sexual function

A comparison of five-year sexual function outcomes, as reported by patients treated with external beam radiotherapy (EBRT) versus combination EBRT plus brachytherapy, indicates that the utilization of vessel-sparing radiation therapy makes cure possible without compromising long-term sexual function, according to research presented today at the American Society for Radiation Oncology’s (ASTRO’s) 56th Annual Meeting. ... Full story

Genetic Discovery Yields Prostate Cancer Test, Promise of Future Therapy

PITTSBURGH – A genetic discovery out of the University of Pittsburgh School of Medicine is leading to a highly accurate test for aggressive prostate cancer and identifies new avenues for treatment. ... Full story

New gene research helps pinpoint prostate cancer risk

Scientists could soon better predict a man's risk of getting prostate cancer after a worldwide team of researchers carried out the largest-ever analysis of the cancer's genetic biomarkers, reported in Nature Genetics today. ... Full story

Genetic testing can identify men at six-fold increased risk of prostate cancer

Scientists can now explain a third of the inherited risk of prostate cancer, after a major international study identified 23 new genetic variants associated with increased risk of the disease. ... Full story

Blood Test for 'Nicked' Receptor Predicts Prostate Cancer Treatment Response

Fast Facts: The study evaluated two groups of 31 men with prostate cancer that had spread and whose blood levels of prostate-specific antigen (PSA) were still rising despite low testosterone levels. Patients whose blood samples contained AR-V7 got no benefit from either enzalutamide or abiraterone. If large-scale studies validate the findings, the investigators say men with detectable blood levels of AR-V7 should avoid these two drugs and instead take other medicines to treat their prostate cancer. ... Full story

Mushroom compound with Vit E suppress prostate cancer tumours

Stopping Australia's most commonly diagnosed cancer - prostate cancer - in its tracks is the goal of scientists around the world. ... Full story

Blood test for 'nicked' protein predicts prostate cancer treatment response

Prostate cancer patients whose tumors contain a shortened protein called AR-V7, which can be detected in the blood, are less likely to respond to two widely used drugs for metastatic prostate cancer, according to results of a study led by researchers at the Johns Hopkins Kimmel Cancer Center. If large-scale studies validate the findings, the investigators say men with detectable blood levels of AR-V7 should avoid these two drugs and instead take other medicines to treat their prostate cancer. A report on the work is described online Sept. 3 in the New England Journal of Medicine. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 139 | displaying: 1 - 10